CAS 278788-60-6 - China Factory, Suppliers, Manufacturers

CAS 278788-60-6, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

(R)-1-Boc-Piperazine-2-Carboxylic Acid CAS 278788-60-6 Purity ≥98.0% High Purity
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.11.14 17:59:34
2022.09.27 01:48:02
2022.08.16 09:24:39
2022.05.22 18:20:38
2022.04.24 10:43:43
2022.01.22 20:51:39

CAS 278788-60-6 - China Factory, Suppliers, Manufacturers

Related Products

(R)-1-Boc-Piperazine-2-Carboxylic Acid CAS 278788-60-6 Purity ≥98.0% High Purity

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Melanotan II (MT-II) CAS 121062-08-6 Peptide Purity (by HPLC) ≥97.0% Factory High Quality

1,2,4-Trichlorobenzene CAS 120-82-1 Purity >99.0% (GC)

(R)-3-Amino-3-Phenylpropionic Acid CAS 13921-90-9 (R)-3-Phenyl-beta-Alanine Purity >98.5% (HPLC) Factory

Triisopropylsilane (TIPS) CAS 6485-79-6 Purity >99.0% (GC) Factory

Acetal CAS 105-57-7 Purity >99.0% (GC) Factory High Quality

Boc-NH2 Boc-Amide CAS 4248-19-5 tert-Butyl Carbamate Purity >99.5% (GC) Factory

Boc-D-Asp-OBzl CAS 92828-64-3 Purity >98.5% (HPLC) Factory

Sodium Citrate Dihydrate CAS 6132-04-3 Purity >99.5% (Titration) Ultrapure For Molecular Biology Factory

5-Methoxyindole CAS 1006-94-6 Purity >99.5% (HPLC) Factory High Quality

4,4'-Dimethoxybenzophenone CAS 90-96-0 Purity >99.5% (GC)

2-Bromobenzyl Alcohol CAS 18982-54-2 Purity >99.0% (GC) Factory

Pyrazine CAS 290-37-9 Purity >99.0% (GC) Factory

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

New COVID treatments offer hope

Yellow phosphorus and phosphoric acid rose together

The “Summit on COVID-19 Diagnostics & Treatment”

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

2022.11.14 17:59:34

2022.09.27 01:48:02

2022.08.16 09:24:39

2022.05.22 18:20:38

2022.04.24 10:43:43

2022.01.22 20:51:39

related search